UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $342,000 Stock Position in Definitive Healthcare Corp. (NASDAQ:DH)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lowered its stake in shares of Definitive Healthcare Corp. (NASDAQ:DH) by 5.3% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 76,610 shares of the company’s stock after selling 4,329 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in Definitive Healthcare were worth $342,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Glenmede Trust Co. NA increased its position in Definitive Healthcare by 41.1% during the third quarter. Glenmede Trust Co. NA now owns 18,423 shares of the company’s stock worth $82,000 after buying an additional 5,362 shares during the last quarter. Dynamic Technology Lab Private Ltd acquired a new stake in shares of Definitive Healthcare in the third quarter valued at approximately $93,000. Algert Global LLC boosted its stake in shares of Definitive Healthcare by 21.9% during the 3rd quarter. Algert Global LLC now owns 282,344 shares of the company’s stock worth $1,262,000 after acquiring an additional 50,700 shares during the period. Charles Schwab Investment Management Inc. increased its holdings in shares of Definitive Healthcare by 5.7% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 436,132 shares of the company’s stock worth $1,950,000 after acquiring an additional 23,706 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA raised its stake in Definitive Healthcare by 36.8% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 6,053,233 shares of the company’s stock valued at $27,058,000 after acquiring an additional 1,626,813 shares during the period. 98.67% of the stock is owned by institutional investors.

Definitive Healthcare Price Performance

Shares of NASDAQ DH opened at $4.18 on Friday. The business has a fifty day moving average price of $4.41 and a two-hundred day moving average price of $4.68. The stock has a market capitalization of $482.89 million, a PE ratio of -1.35, a P/E/G ratio of 3.29 and a beta of 1.40. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.49 and a quick ratio of 2.49. Definitive Healthcare Corp. has a fifty-two week low of $3.19 and a fifty-two week high of $10.62.

Insider Activity at Definitive Healthcare

In other Definitive Healthcare news, insider William Moschella sold 45,000 shares of the firm’s stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $4.70, for a total value of $211,500.00. Following the sale, the insider now owns 433,830 shares of the company’s stock, valued at approximately $2,039,001. This trade represents a 9.40 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 14.84% of the stock is owned by insiders.

Analyst Ratings Changes

A number of equities analysts have commented on DH shares. BTIG Research started coverage on shares of Definitive Healthcare in a research report on Tuesday, September 17th. They set a “buy” rating and a $7.00 price objective for the company. Needham & Company LLC reaffirmed a “hold” rating on shares of Definitive Healthcare in a report on Friday, November 8th. Finally, Stephens assumed coverage on shares of Definitive Healthcare in a report on Friday. They issued an “equal weight” rating and a $5.00 price target on the stock. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and three have given a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $5.72.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.